Cell Source, Inc. (CLCS) › Cash & EquivalentsCell Source, Inc. (CLCS) — Cash & EquivalentsAnnual figures by fiscal year, from SEC filings.2012: $161.3K2013: $28.9K2014: $19.5K2015: $6.9K2016: $3.7K2017: $371.0K2018: $18.9K2019: $27.9K2020: $241.6K2021: $93.1K2022: $222.7K$222.7K2012Cash & Equivalents (USD)2022Fiscal YearCash & EquivalentsChange YoY2022$222.7K+139.2%2021$93.1K-61.5%2020$241.6K+765.8%2019$27.9K+47.4%2018$18.9K-94.9%2017$371.0K+9834.4%2016$3.7K-46.2%2015$6.9K-64.4%2014$19.5K-32.5%2013$28.9K-82.1%2012$161.3K—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share